5 assets in Primary Cutaneous B-Cell Lymphoma

Therapeutic assets addressing Primary Cutaneous B-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Primary Cutaneous B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)